Netramark Hldgs Inc (AINMF)

$0.73 +0.00 (0.07%)
Market Cap 66.76M
Revenue (ttm) 310,000.00
Net Income (ttm) -3.73M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,203.23%
Debt to Equity Ratio 0.00
Volume 4,400
Avg Vol 6,164
Day's Range N/A - N/A
Shares Out 91.83M
Stochastic %K 34%
Beta N/A
Analysts Strong Buy
Price Target $2.25

Company Profile

NetraMark Holdings Inc. provides AI-powered insights and software solutions to trial sponsors, clinical research organizations, and biotechnology companies worldwide. It operates NetraAI platform, an advanced machine learning system purpose-built for analyzing complex clinical trial data to identify meaningful patient subpopulations. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. NetraMark Holdings Inc. was founded in 2016...

Industry: Health Information Services
Sector: Healthcare
Phone: 403 681 2549
Address:
1655 Dupont Street, Suite 101, Toronto, Canada
ZacksSCR
ZacksSCR Jan. 13 at 8:29 PM
$AINMF: Entering 2026 With Strong Foundation for Growth https://buff.ly/krdfIxj
0 · Reply
ZacksSCR
ZacksSCR Dec. 5 at 7:24 PM
$AINMF: Growing Number of Agreements Underscore Expected Benefits of AI De-Risking Solutions for Clinical Research https://buff.ly/voxKWoM
0 · Reply
SmallCapComms
SmallCapComms Nov. 17 at 6:50 PM
$AINMF Just interviewed @NetraMark_AI $AIAI.CN / $AINMF one of the most interesting AI companies in the clinical-trial space. We covered: • Why 60–90% of trials fail • How “personas” can save or rescue Phase 2/3 studies • Their partnership with Worldwide Clinical Trials • FDA meeting coming this December • NIMH collaboration + peer-reviewed publication This company is doing things most AI companies can’t — explainable, regulator-aligned, real-world AI. Not investment advice. I do not own shares and I was not paid. Full interview 👇 🎥 https://youtu.be/Ae2fSzLXUiE?si=97M_4JPbJ1rulwW_
0 · Reply
ZacksSCR
ZacksSCR Aug. 7 at 4:24 PM
$AINMF: Believe Recent Agreements Illustrate Growing Traction of AI Solutions to De-Risk Clinical Research https://buff.ly/nrwUA1n
0 · Reply
ZacksSCR
ZacksSCR Jul. 28 at 5:13 PM
$AINMF: NetraMark aims to solve one of pharma’s biggest challenges: understanding patient variability in trials. CEO George Achilleos explains the company’s unique approach. https://buff.ly/6fXNxqj
0 · Reply
ZacksSCR
ZacksSCR Jul. 11 at 5:10 PM
$AINMF Netramark is an AI company helping pharma companies de-risk clinical trials and increase their efficiency by identifying patient subpopulations that may negatively impact outcomes. https://youtu.be/3KuYLJZUN6o #AI #MachineLearning #ClinicalTrials
1 · Reply
ZacksSCR
ZacksSCR Jul. 1 at 7:22 PM
$AINMF: Solutions to De-Risk Clinical Research Trials Expected to Gain Substantial Traction; Initiating Coverage https://buff.ly/deRmCWd
0 · Reply
Clkrrb
Clkrrb Apr. 4 at 5:13 AM
$AINMF What top 5 pharmaceutical company are they working with?
0 · Reply
katorvix
katorvix Dec. 11 at 8:07 PM
$AINMF 👀
0 · Reply
newsfile_corp
newsfile_corp Oct. 2 at 12:03 PM
https://nfne.ws/225319 $AINMF #CantechLetter #CSEStocks #OTC #OTCMarkets #OTCStocks #SmallCaps #Investing
0 · Reply
Latest News on AINMF
No data available.
ZacksSCR
ZacksSCR Jan. 13 at 8:29 PM
$AINMF: Entering 2026 With Strong Foundation for Growth https://buff.ly/krdfIxj
0 · Reply
ZacksSCR
ZacksSCR Dec. 5 at 7:24 PM
$AINMF: Growing Number of Agreements Underscore Expected Benefits of AI De-Risking Solutions for Clinical Research https://buff.ly/voxKWoM
0 · Reply
SmallCapComms
SmallCapComms Nov. 17 at 6:50 PM
$AINMF Just interviewed @NetraMark_AI $AIAI.CN / $AINMF one of the most interesting AI companies in the clinical-trial space. We covered: • Why 60–90% of trials fail • How “personas” can save or rescue Phase 2/3 studies • Their partnership with Worldwide Clinical Trials • FDA meeting coming this December • NIMH collaboration + peer-reviewed publication This company is doing things most AI companies can’t — explainable, regulator-aligned, real-world AI. Not investment advice. I do not own shares and I was not paid. Full interview 👇 🎥 https://youtu.be/Ae2fSzLXUiE?si=97M_4JPbJ1rulwW_
0 · Reply
ZacksSCR
ZacksSCR Aug. 7 at 4:24 PM
$AINMF: Believe Recent Agreements Illustrate Growing Traction of AI Solutions to De-Risk Clinical Research https://buff.ly/nrwUA1n
0 · Reply
ZacksSCR
ZacksSCR Jul. 28 at 5:13 PM
$AINMF: NetraMark aims to solve one of pharma’s biggest challenges: understanding patient variability in trials. CEO George Achilleos explains the company’s unique approach. https://buff.ly/6fXNxqj
0 · Reply
ZacksSCR
ZacksSCR Jul. 11 at 5:10 PM
$AINMF Netramark is an AI company helping pharma companies de-risk clinical trials and increase their efficiency by identifying patient subpopulations that may negatively impact outcomes. https://youtu.be/3KuYLJZUN6o #AI #MachineLearning #ClinicalTrials
1 · Reply
ZacksSCR
ZacksSCR Jul. 1 at 7:22 PM
$AINMF: Solutions to De-Risk Clinical Research Trials Expected to Gain Substantial Traction; Initiating Coverage https://buff.ly/deRmCWd
0 · Reply
Clkrrb
Clkrrb Apr. 4 at 5:13 AM
$AINMF What top 5 pharmaceutical company are they working with?
0 · Reply
katorvix
katorvix Dec. 11 at 8:07 PM
$AINMF 👀
0 · Reply
newsfile_corp
newsfile_corp Oct. 2 at 12:03 PM
https://nfne.ws/225319 $AINMF #CantechLetter #CSEStocks #OTC #OTCMarkets #OTCStocks #SmallCaps #Investing
0 · Reply
Jpetersonlions
Jpetersonlions Dec. 27 at 5:28 PM
$AINMF https://www.newswire.ca/news-releases/netramark-signs-two-contracts-with-large-biopharmaceutical-company-to-enhance-clinical-trial-insights-814623532.html
0 · Reply
Jpetersonlions
Jpetersonlions Dec. 20 at 7:01 PM
$AINMF https://www.newswire.ca/news-releases/netramark-signs-two-contracts-with-large-biopharmaceutical-company-to-enhance-clinical-trial-insights-814623532.html#:~:text=NetraMark%20is%20a%20company%20focused,targeted%20at%20the%20Pharmaceutical%20industry.
0 · Reply
Jpetersonlions
Jpetersonlions Dec. 5 at 11:34 PM
$AINMF $GME $AMC $KOSS .27 cents a share small float, AI + expediting clinical trial drugs big risk big reward get some
0 · Reply
Jpetersonlions
Jpetersonlions Dec. 5 at 10:41 PM
$AINMF LETS GO BABY
0 · Reply
fla
fla May. 16 at 12:15 PM
$AINMF [15s. delayed]: Issued Press Release on May 16, 08:15:00: NETRAMARK, THE FIRST PUBLIC AI COMPANY TO LAUNCH CLINICAL TRIAL DE-RISKIN https://s.flashalert.me/veSvv
0 · Reply
Stock_Titan
Stock_Titan May. 16 at 12:15 PM
$AINMF NETRAMARK, THE FIRST PUBLIC AI COMPANY TO LAUNCH CLINICAL TRIAL DE-RISKING TECHNOLOGY THAT INTEGRATES CHATGPT https://www.stocktitan.net/news/AINMF/netramark-the-first-public-ai-company-to-launch-clinical-trial-de-fuoqldvygd9v.html #clinicaltrial
0 · Reply